“We are going to evaluate how the commercialization of this compound fits in with our organization model at Adastra in an effort to posture ourselves to help the desire for a safe supply of copyright,” said chief govt officer Michael Forbes in the information release. The business explained to VICE News it wouldn't be commenting further more.